Dr. Smith et al., ION MICROSCOPY IMAGING OF B-10 FROM P-BORONOPHENYLALANINE IN A BRAIN-TUMOR MODEL FOR BORON NEUTRON-CAPTURE THERAPY, Cancer research, 56(19), 1996, pp. 4302-4306
Boron neutron capture therapy (BNCT), a binary treatment modality that
can potentially irradiate tumor tissue within cellular dimensions, is
critically dependent on the preferential delivery of B-10 to individu
al neoplastic cells, In this study, ion microscopy was used to quantit
atively evaluate the selectivity of p-boronophenylalanine-fructose (BP
A-F) in the rat 9L gliosarcoma brain tumor model. With a spatial resol
ution of similar to 0.5 mu m, ion microscopy Images show that BPA-F de
livers 3.5 times more boron to the main tumor mass [99 +/- 36 mu g/g t
issue (mean +/- SD)] than to the contiguous normal brain (27 +/- 12 mu
g/g tissue). A similar, but lower, accumulation was observed away fro
m the main tumor mass in small clusters of neoplastic cells (47 +/- 15
mu g/g tissue) invading the surrounding brain (16 +/- 8 mu g/g tissue
), These findings establish for the first time the selectivity of BPA-
F to the neoplastic cells invading the normal brain and provide a much
-needed baseline measurement of the distribution of a clinically appro
ved BNCT drug, Given the propensity for malignant brain tumors to infi
ltrate the surrounding normal brain, these observations have particula
r significance for clinical trials of BNCT for human glioblastoma mult
iforme using the drug BPA-F.